Considering that obesity has become an important health problem in the recent century with an estimated one billion people overweight and at least 300 million obese adults in the world [39], our results suggest PXR may represent a novel therapeutic target for prevention and treatment of obesity and type-2 diabetes. The gene discussed is NR1I2; the disease is Obesity.